Although IL-17, as a hallmark cytokine of TH17 cells, plays critical roles in the pathogenesis of autoimmune diseases, targeting IL-17 alone with anti-IL-17 antibodies was not sufficient to improve clinical end points (54). The gene discussed is IL17A; the disease is autoimmune disease.